KRAS G12C Lung Cancer trials recruiting in Alaska

Fewer than 3 recruiting trials found.

All KRAS G12C Lung Cancer trials nationally

Cities in Alaska

Recruiting trials in Alaska

• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
  NCT06793215 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Alaska: Anchorage